These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15741746

  • 21. The effects of antidepressants on psychomotor function with particular reference to reboxetine.
    Hindmarch I.
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S17-21; discussion S71-3. PubMed ID: 9169307
    [Abstract] [Full Text] [Related]

  • 22. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.
    Dubini A, Bosc M, Polin V.
    J Psychopharmacol; 1997 Apr; 11(4 Suppl):S17-23. PubMed ID: 9438229
    [Abstract] [Full Text] [Related]

  • 23. The antidepressant efficacy of reboxetine in patients with severe depression.
    Montgomery S, Ferguson JM, Schwartz GE.
    J Clin Psychopharmacol; 2003 Feb; 23(1):45-50. PubMed ID: 12544375
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis.
    Pjrek E, Konstantinidis A, Assem-Hilger E, Praschak-Rieder N, Willeit M, Kasper S, Winkler D.
    J Psychiatr Res; 2009 May; 43(8):792-7. PubMed ID: 19230909
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression.
    Hegerl U, Mergl R, Henkel V, Pogarell O, Müller-Siecheneder F, Frodl T, Juckel G.
    Psychopharmacology (Berl); 2005 Feb; 178(1):58-66. PubMed ID: 15316714
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC.
    Biol Psychiatry; 2007 Dec 01; 62(11):1217-27. PubMed ID: 17588546
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.
    Eyding D, Lelgemann M, Grouven U, Härter M, Kromp M, Kaiser T, Kerekes MF, Gerken M, Wieseler B.
    BMJ; 2010 Oct 12; 341():c4737. PubMed ID: 20940209
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.